Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes
Georgios Schoretsanitis, lead author of a separate study, acknowledged no clear evidence of a causal relationship between semaglutide and suicidal ideation, but noted a potential association
Some children with both GDH-HI and epilepsy may also have behavioral problems, such as social disorders, attention deficit hyperactivity disorder (ADHD)
Compared to existing mid-gestation tools, such as the IBP4/SHBG ratio, this panel showed superior performance and is compatible with standard clinical laboratory platforms
1 in 3 Say Anticipated Savings Drove Their GLP-1 Decision Nearly half of respondents 45% say they anticipated saving money on expenses such as food, restaurants, or fitness before starting a GLP-1